Current role
Mr. Chopra
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mr. Chopra
The proxy statement of Edwards Lifesciences Corp reports total compensation of $4,695,742 for Mr. Chopra in fiscal 2025, including a base salary of $671,042. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Edwards Lifesciences Corp (EW)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Edwards Lifesciences Corp
Other people whose current roles at this company are on record from its filings.
- Bernard Zovighian CEO, Board Member
- Mr. Mussallem CEO
- Mr. Zovighian CEO
- Mr. Ullem CFO
- Scott Ullem CFO
- Theodora Mistras CFO
- Andrew M. Dahl Chief Accounting Officer
- Bernard J. Zovighian Board Member
- David T. Feinberg, M.D. Board Member
- David T. Feinberg, MD Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Edwards Lifesciences Corp (EW) | Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies | $671,042 | $4,695,742 |
| 2024 | Edwards Lifesciences Corp (EW) | Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies | $627,346 | $3,720,491 |
Recent activity
No call appearances or filed executive changes recorded yet.